is novocure a good investment?
Highly Rated Cancer Treatment Stock Investor's Business Daily has several strong ratings on Novocure stock. Shares have a Composite Rating of 93. This puts Novocure stock in the top 7% of all stocks in terms of key fundamental and technical growth rates.